Cargando…
Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) can increase survival of colorectal cancer (CRC) patients with peritoneal metastases (PM). This treatment is associated with high morbidity and mortality rates. Therefore, improvement of patient selection is necessary....
Autores principales: | Sluiter, N. R., de Cuba, E. M. V., Kwakman, R., Meijerink, W. J. H. J., Delis-van Diemen, P. M., Coupé, V. M. H., Beliën, J. A. M., Meijer, G. A., de Hingh, I. H. J. T., te Velde, E. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799792/ https://www.ncbi.nlm.nih.gov/pubmed/26873137 http://dx.doi.org/10.1007/s10585-016-9779-9 |
Ejemplares similares
-
Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer
por: de Cuba, E. M. V., et al.
Publicado: (2016) -
Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
por: de Wit, Meike, et al.
Publicado: (2012) -
Tailoring heated intraperitoneal mitomycin C for peritoneal metastases originating from colorectal carcinoma: a translational approach to improve survival
por: Kwakman, R, et al.
Publicado: (2015) -
Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression
por: de Wit, Meike, et al.
Publicado: (2017) -
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer
por: Gamboa, Adriana C., et al.
Publicado: (2019)